Top Tweets for #LoDoCo2
#LateBreaking trial 🔥 #CLEAR
#Colchicine 💊may NOT be effective in #STEMI and large #NSTEMI with no difference found in outcomes! 💔
Largest Colchicine trial with over 7000 patients 👏 #COLCOT #LODOCO2 #CHANCE3 #CONVINCE
#TCT2024 @crfheart @TCTConference @TCTConference 🫀

💥📜 Read our paper on #Colchicine in #CVD🫀& #atherosclerosis
#COLCOT #LoDoCo & #LoDoCo2 ➡️significant🫀benefit & #FDA approval in #2023 for CVD
More to come #Colchicine from our group..
@HarborUCLA @NCHRooneyHeart @BudoffMd @JairoaldanaMD @JonathonLeipsic @FloridaACC #yesCCT

_FDA approves #Colchicine to ⬇️risk of MI ,stroke,coronary revascularization, & CV ☠️ in adult patient with established atherosclerotic disease or with multiple risk factors for CV disease.
_0.5mg daily recommended , _hsCRP> 2mg/dL starting point
#LoDoCo2 , #COLCOT 1/2

In this #LoDoCo2 presentation, Dr Aernoud Fiolet @UMCU_Intl covers the trial design and main results. Click here to watch: https://t.co/MxVNuEu7eB
Not intended for UK or US HCPs.
#Cardiology #CardioTwitter #CardioNerds

In this #LoDoCo2 presentation, Dr Aernoud Fiolet @UMCU_Intl covers the trial design and main results. Click here to watch: https://t.co/HUrfau5Qx9
Not intended for UK or US HCPs.
#Cardiology #CardioTwitter #CardioNerds

@CardioNerdsJC Yes, but I eagerly await more data which will provide a more definitive answer. In MI, inflammation plays a role. In progressive CAD, inflammation plays a role. The proper patient to identify for these therapies is critical for successful implementation of findings.
#CardsJC
@CardioNerdsJC A1: #CardsJC The inflammatory basis of atherogenesis well-established. So why wouldn't such medications that target inflammation work? We have been asking this for a looonnngggg time! But today we get to discuss a really important trial! #LoDoCo2
Join @CardioNerds this Tuesday evening to discuss the promising effects of colchicine on CV outcomes of patients with chronic coronary disease! #CardsJC #LoDoCo2 trial #ACCMedStudent 📝
📚@CardioNerdsJC #CardsJC is BAAAAACK!
Join us this 📅TUESDAY 8PM EST right here on #cardiotwitter for an amazing discussion about the #LoDoCo2 trial⚖️
Review the trial summary 👇👇👇🔗https://t.co/wOkqwOMvpZ
Learn more about #CardsJC 👇👇👇
https://t.co/65WWG9PZH1

Check it out @CardioNerds 🤓! My amazing cofellows and I in #HouseJones will discuss #LoDoCo2 💊 at this week’s #CardsJC @a_h_ghoneem @IsaMathiasMD @CBlumenthal2 @CardioAtHeart
📚@CardioNerdsJC #CardsJC is BAAAAACK!
Join us this 📅TUESDAY 8PM EST right here on #cardiotwitter for an amazing discussion about the #LoDoCo2 trial⚖️
Review the trial summary 👇👇👇🔗https://t.co/wOkqwOMvpZ
Learn more about #CardsJC 👇👇👇
https://t.co/65WWG9PZH1

📚@CardioNerdsJC #CardsJC is BAAAAACK!
Join us this 📅TUESDAY 8PM EST right here on #cardiotwitter for an amazing discussion about the #LoDoCo2 trial⚖️
Review the trial summary 👇👇👇🔗https://t.co/wOkqwOMvpZ
Learn more about #CardsJC 👇👇👇
https://t.co/65WWG9PZH1

@Mu7ibullah @abledoc @spkalantri @PriyankaPulla @drkrvcvijay Reassuringly there are 2 trials #LoDoCo & #LoDoCo2 that have established the safety of Low Dose #Colchicine
(Click on hashtags above for more details)
https://t.co/w5IBF0kXxA
@Mu7ibullah @abledoc @spkalantri @PriyankaPulla There is no moral hazard there
Diarrhea has known treatment /medications
The danger is colchicine overdose/poisoning. There is no cure for that.
Which is why its prescribed only in rare conditions
@drkrvcvijay
📌El renacimiento de la colchicina en enfermedad coronaria🫀
Comentario de los estudios #COLCOT & #LoDoCo2
Pacientes con #IC & ERC fueron excluidos.
https://t.co/GbR3t1babW
Vía @ESC_Journals

#SIC2020 #SIC81 | Filippo Crea [@ehj_ed] discusses results of the #LoDoCo2 trial.
Our interview with @ImazioMassimo: https://t.co/243oSvxk0d
![Cardioinfo_it's tweet photo. #SIC2020 #SIC81 | Filippo Crea [@ehj_ed] discusses results of the #LoDoCo2 trial.
Our interview with @ImazioMassimo: https://t.co/243oSvxk0d https://t.co/2zdnADRwSP](https://pbs.twimg.com/media/Epbe8PXXIAAEcEs.jpg)
Colchicine Attenuates Inflammation Beyond the Inflammasome in Chronic Coronary Artery Disease: A #LoDoCo2 Proteomic Substudy https://t.co/XvMyR9g4fm #AHAJournals @TjerkOpstal @radboudumc

#Editorial: Colchicine for secondary CV prevention: Comparison of #COLCOT, #COPS and #LoDoCo2 https://t.co/Boet0C1F5h #AHAjournals

T-cell immune responses in #AcuteCoronarySyndrome are driven by #interleukin 7 & 15. Is there a role for IL-7/IL-15 signaling inhibition with #Tofacitinib in #MI? https://t.co/aqcZP9tQo2
@CVR_TomaszGuzik @AIAntonopoulos
#inflammation #atherosclerosis #CardiovascularResearch

Last Seen Hashtags on Sotwe
blueheartofeurope
Seen from United States
鱼
Seen from India
Athira
Seen from Oman
istanbulgay
Seen from Turkey
หีน้องสาว
Seen from Thailand
padmajagogoi
Seen from India
hawaii
Seen from United Kingdom
kayserigay
Seen from Germany
pyt
Seen from South Africa
momson()+*+*+filter:native_video
Seen from Russia
Most Popular Users

Elon Musk 
@elonmusk
240.9M followers

Barack Obama 
@barackobama
119.2M followers

Donald J. Trump 
@realdonaldtrump
111.8M followers

Cristiano Ronaldo 
@cristiano
111.4M followers

Narendra Modi 
@narendramodi
107M followers

Rihanna 
@rihanna
97.9M followers

NASA 
@nasa
92.2M followers

Justin Bieber 
@justinbieber
91.1M followers

KATY PERRY 
@katyperry
88.1M followers

Taylor Swift 
@taylorswift13
82M followers

Lady Gaga 
@ladygaga
73.5M followers

Virat Kohli 
@imvkohli
70.6M followers

Kim Kardashian 
@kimkardashian
70M followers

YouTube 
@youtube
68.7M followers

Bill Gates 
@billgates
64.1M followers

Neymar Jr 
@neymarjr
63.4M followers

The Ellen Show
@theellenshow
62.4M followers

CNN 
@cnn
61.9M followers

Selena Gomez 
@selenagomez
61.2M followers

X 
@x
60.8M followers




























